Cargando…
(23)Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy
In this pilot study we tested whether a low dose application of a mild diuretic substance such as eplerenone is beneficial in early stages of Duchenne muscular dystrophy using (23)Na und (1)H imaging, myometry, and clinical testing versus the glucocorticoid gold standard. Two 7-years old patients wi...
Autores principales: | A. Glemser, Philip, Jaeger, Heike, M. Nagel, Armin, E. Ziegler, Andreas, Simons, David, Schlemmer, Heinz-Peter, Lehmann-Horn, Frank, Jurkat-Rott, Karin, Weber, Marc-André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore SRL
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479105/ https://www.ncbi.nlm.nih.gov/pubmed/28690388 |
Ejemplares similares
-
Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012) -
Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation
por: Breitenbach, Simon, et al.
Publicado: (2016) -
The role of fibrosis
in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012) -
Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
por: Raman, Subha V., et al.
Publicado: (2017) -
I-10
Pathogenesis of muscle degeneration
in periodic paralyses and DMD
por: Lehmann-Horn, F., et al.
Publicado: (2011)